B
13.14
1.22 (10.23%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Biohaven Ltd. | 看涨 | 看跌 |
AIStockmoo 评分
2.0
| 分析师共识 | 1.5 |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 2.00 |
|
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.96% |
| 机构持股比例 | 90.75% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Suvretta Capital Management, Llc | 30 Sep 2025 | 5,620,271 |
| Bellevue Group Ag | 30 Sep 2025 | 2,802,853 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 22.00 (RBC Capital, 67.43%) | 购买 |
| 中 | 15.00 (14.16%) | |
| 低 | 9.00 (Bernstein, -31.51%) | 保留 |
| 平均值 | 14.89 (13.32%) | |
| 总计 | 6 购买, 3 保留 | |
| 平均价格@调整类型 | 9.68 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| RBC Capital | 21 Jan 2026 | 22.00 (67.43%) | 购买 | 12.87 |
| 06 Nov 2025 | 9.00 (-31.51%) | 保留 | 8.53 | |
| Morgan Stanley | 06 Jan 2026 | 21.00 (59.82%) | 购买 | 9.62 |
| 18 Nov 2025 | 26.00 (97.87%) | 购买 | 9.45 | |
| HC Wainwright & Co. | 26 Dec 2025 | 11.00 (-16.29%) | 保留 | 11.15 |
| 03 Dec 2025 | 11.00 (-16.29%) | 保留 | 9.12 | |
| UBS | 26 Nov 2025 | 11.00 (-16.29%) | 保留 | 9.48 |
| JP Morgan | 20 Nov 2025 | 15.00 (14.16%) | 购买 | 9.63 |
| BTIG | 18 Nov 2025 | 16.00 (21.77%) | 购买 | 9.45 |
| 06 Nov 2025 | 16.00 (21.77%) | 购买 | 8.53 | |
| Citigroup | 13 Nov 2025 | 14.00 (6.54%) | 购买 | 8.08 |
| Bernstein | 06 Nov 2025 | 9.00 (-31.51%) | 保留 | 8.53 |
| TD Cowen | 05 Nov 2025 | 15.00 (14.16%) | 购买 | 8.34 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合